disopyramide, (s)-isomer has been researched along with vincristine in 1 studies
Studies (disopyramide, (s)-isomer) | Trials (disopyramide, (s)-isomer) | Recent Studies (post-2010) (disopyramide, (s)-isomer) | Studies (vincristine) | Trials (vincristine) | Recent Studies (post-2010) (vincristine) |
---|---|---|---|---|---|
5 | 0 | 0 | 246 | 0 | 117 |
Protein | Taxonomy | disopyramide, (s)-isomer (IC50) | vincristine (IC50) |
---|---|---|---|
Tubulin beta-4A chain | Homo sapiens (human) | 0.5 | |
Tubulin beta chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-3C chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-1B chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-4A chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-4B chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-3 chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-2A chain | Homo sapiens (human) | 0.5 | |
Beta-tubulin | Leishmania donovani | 1 | |
Tubulin beta-8 chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-2B chain | Bos taurus (cattle) | 1.8 | |
Tubulin alpha-3E chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-1A chain | Homo sapiens (human) | 0.5 | |
Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.8 | |
Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.8 | |
Tubulin alpha-1C chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-6 chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-2B chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-1 chain | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
1 other study(ies) available for disopyramide, (s)-isomer and vincristine
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |